Research map: Patterns of Antidiabetic Therapy and Associated Metabolic Profiles in Routine Clinical Practice

Back to the article

Papers in this map

  1. Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused · Md. Jamal Hossain · 2024 · 911 citations · Cited by this paper
  2. Adherence to the 24 h Movement Guidelines and Type 2 Diabetes Risk in the SUN Project: A Prospective Cohort Study · 2026 · Related
  3. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors · João Leonardo Silveira Rossi · 2021 · 614 citations · Cited by this paper
  4. Assessing and Predicting Medication Adherence and Diabetes Control Among African American Adults with Uncontrolled Diabetes · 2026 · Related
  5. DPP-4 Inhibitors · Dror Dicker · 2011 · 229 citations · Cited by this paper
  6. Sexual Dimorphism in the Association Between Vitamin D and Depressive Symptoms in Diabetic Patients and the Mediating Role of BMI: A Cross-Sectional Study · 2026 · Related
  7. The Current and Potential Therapeutic Use of Metformin—The Good Old Drug · Józef Drzewoski · 2021 · 159 citations · Cited by this paper
  8. From Device Data to Trusted Decision Support: Building the Foundation for AI in Hospital Insulin Management · 2026 · Related
  9. Association of metabolic syndrome and chronic kidney disease · Florian Gunnar Scurt · 2023 · 156 citations · Cited by this paper
  10. Negative Association of SGLT2 Inhibitors with Epilepsy Risk Compared with DPP-4 Inhibitors in Type 2 Diabetes: A Target Trial Emulation · 2026 · Related
  11. Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies · Nawfal Hasan Siam · 2024 · 124 citations · Cited by this paper
  12. Circadian Regulation of Glucose Metabolism: Implications for Pathogenesis and Chronotherapy of Type 2 Diabetes · 2026 · Related
  13. Metformin in patients with chronic kidney disease: strengths and weaknesses · Ana Rocha · 2012 · 51 citations · Cited by this paper
  14. Experiences, Needs, and Beliefs Regarding Footwear Among People with Diabetes Mellitus in Spain: A Qualitative Focus Group Study Protocol · 2026 · Related
  15. Systematic review of metformin monotherapy and dual therapy with sodium glucose co-transporter 2 inhibitor (SGLT-2) in treatment of type 2 diabetes mellitus · Nagashekhara Molugulu · 2017 · 34 citations · Cited by this paper
  16. Relationship Between Diabetes Stigma and Outpatient Medical Costs in Patients with Type 2 Diabetes: A Cross-Sectional Study · 2026 · Related
  17. Effect of Dipeptidyl Peptidase-4 Inhibitors on Plasma Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials · Amirhossein Sahebkar · 2016 · 23 citations · Cited by this paper
  18. Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes · Sumaya N. Almohareb · 2024 · 21 citations · Cited by this paper
  19. Hemodynamic Effects of SGLT2 Inhibitors in Patients with and Without Diabetes Mellitus—A Narrative Review · Roxana Daniela Brata · 2024 · 19 citations · Cited by this paper
  20. Incretin-Based Therapies: Focus on Effects Beyond Glycemic Control Alone · Jaime A. Davidson · 2013 · 15 citations · Cited by this paper
  21. SGLT-2 Inhibitors and GLP-1 Receptor Agonists as Combination Therapy in Type 2 Diabetes · Aris Liakos · 2026 · 11 citations · Cited by this paper
  22. The Impact of Dyslipidemia on the Clinical Profile of Patients With Uncontrolled Diabetes · Lorena Păduraru · 2025 · 11 citations · Cited by this paper
  23. Poor Glycemic Control and Its Predictors Among Type 2 Diabetes Patients: Insights From a Single‐Centre Retrospective Study in Ghana · Samuel Kyeremeh Adjei · 2025 · 9 citations · Cited by this paper
  24. SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era · Konstantinos Grigoriou · 2025 · 9 citations · Cited by this paper
  25. Kidney function decline mediates the adverse effects of arterial stiffness on all-cause and cardiovascular disease mortality in Cardiovascular-Kidney-Metabolic syndrome population: A cohort study · Song Liu · 2025 · 9 citations · Cited by this paper
  26. Effects of SGLT2 Inhibitors on Clinical Outcomes, Symptoms, Functional Capacity, and Cardiac Remodeling in Heart Failure: A Comprehensive Systematic Review and Multidomain Meta-Analysis of Randomized Trials · Olivia-Maria Bodea · 2026 · 9 citations · Cited by this paper
  27. Metformin Beyond Glycemic Control: Cardiovascular Protection and Diabetes Prevention · George Ε. Zakynthinos · 2026 · 9 citations · Cited by this paper
  28. Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care · Domingo Orozco‐Beltrán · 2024 · 8 citations · Cited by this paper
  29. Complementary Yet Distinct Roles of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction · Nóra Homoródi · 2025 · 8 citations · Cited by this paper
  30. Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 · Caturano, Alfredo · 2024 · 7 citations · Cited by this paper
  31. Molecular and clinical profiles of T2DM, dyslipidemia, and periodontitis: insights into inflammatory and metabolic dysregulation · Peace Ngozi Okoro · 2025 · 6 citations · Cited by this paper
  32. The predictive potential of surrogate indicators of insulin resistance for type 2 diabetic kidney disease · Qun Tian · 2026 · 3 citations · Cited by this paper
  33. Cardiometabolic Risk Profiles Associated with Chronic Gastrointestinal Symptoms in Adults: A Cross-Sectional Exploratory Analysis Using Routine Clinical Markers · Ramona Alina Tomuța · 2026 · 3 citations · Cited by this paper
  34. Revolutionizing type 2 diabetes management: the role of the pharmacist in unlocking the potential of tirzepatide · David Banji · 2025 · 3 citations · Cited by this paper
  35. Haemoglobin A1c (HbA1c): clinical relevance, history, and role in diabetes mellitus management – a South African perspective · Barney Jordaan · 2025 · 2 citations · Cited by this paper
  36. Evaluating Cardio-Protective Molecules by Efficacy Based on Weight Reduction and HbA1c Targets · Teodor Salmen · 2025 · 1 citation · Cited by this paper
  37. Untitled · Cited by this paper

Source: OpenAlex (CC0)